New ISR Report Provides Insight into Bladder Cancer Market, Clinical Pipeline

Informing the pharmaceutical drug development and commercialization industry

Cary, N.C. – April 15, 2014 – Industry Standard Research (ISR) is announcing the release of its latest report entitled “Bladder Cancer: Disease and Pipeline Analysis.”  This report provides an overview of the current and future bladder cancer clinical development market, the activities of the key market players, and an outline of trial and commercial regulatory environments.

“The latest figures from the World Health Organization show that bladder cancer has a worldwide incidence of almost 430,000 diagnosed cases per year.  This constitutes 3.1% of cancer incidence, making it the 9^th most commonly diagnosed cancer globally,” explained Andrew Schafer, President of ISR.  “There are currently more than 100 active clinical trials for bladder cancer, making this a very dynamic clinical development space.”

ISR’s Bladder Cancer report provides:

• Insight into bladder cancer epidemiology
• Incidence and mortality rates in both major and emerging markets
• A look into the current treatments for bladder cancer by disease stage and therapy type
• An environmental analysis of the major and emerging markets by:
  • Patient Population and Product Environment
  • Trial and Recruitment Environment
  • Regulatory Environment
  • Competitive Product Landscape
  • Pricing and Reimbursement Environment
• A unique view into new therapies in active development

“With these data,” Schafer continued, “sponsors can identify and enhance commercial and development opportunities, plan how products currently in development could impact this market, understand competitor involvement, and better plan clinical trial strategies.”

For more information on ISR’s “Bladder Cancer: Disease and Pipeline Analysis” report, please visit ISR’s report page at https://isrreports.com/product/bladder-cancer-disease-pipeline-analysis/.

About Industry Standard Research

Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience, ISR delivers an unmatched level of domain expertise.  For more information about our off-the-shelf intelligence and custom research offerings, please visit the company’s Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on Twitter @ISRreports.